U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07288619) titled 'Therapeutic Efficacy of Nutritional Supplementation in Cachexia Associated With Chronic Pulmonary Disease' on Nov. 20.
Brief Summary: Pulmonary cachexia, observed in individuals with chronic obstructive pulmonary disease (COPD) is a multifactorial syndrome characterized by disruptions in energy metabolism, increased protein degradation, and an impaired capacity to preserve muscle mass. These metabolic disturbances not only exacerbate the underlying respiratory condition but also significantly contribute to elevated mortality rates among affected individuals.
Current therapeutic strategies for managing cachexia primarily emphasize p...